SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001599901-24-000056
Filing Date
2024-04-26
Accepted
2024-04-26 16:12:21
Documents
17
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A rna-20240426.htm   iXBRL DEF 14A 904099
3 rna-20240426_g1.jpg GRAPHIC 43016
4 rna-20240426_g2.jpg GRAPHIC 36406
5 rna-20240426_g3.jpg GRAPHIC 131697
6 rna-20240426_g4.jpg GRAPHIC 125556
7 rna-20240426_g5.jpg GRAPHIC 1379732
8 rna-20240426_g6.jpg GRAPHIC 275651
  Complete submission text file 0001599901-24-000056.txt   6096423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20240426.xsd EX-101.SCH 943
20 EXTRACTED XBRL INSTANCE DOCUMENT rna-20240426_htm.xml XML 124620
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39321 | Film No.: 24883866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)